|
National News Advocates Say AIDS Vaccine Researchers Need to Break Through Blacks' Mistrust of Medical CommunityFebruary 26, 2003 Researchers trying to learn why an AIDS vaccine appeared to work well in a small number of black volunteers may have trouble finding people for further studies, advocates and educators warn. Suspicion of medical research runs deep among many blacks, they say, and the reason can be summarized in one word: Tuskegee. In the federal government's Tuskegee Syphilis Study, researchers withheld medical treatment from poor, black men in Macon County, Ala. The men were not told they had syphilis, and they were not treated even after penicillin became available. By 1972, when the study was exposed, 128 men had died of syphilis or related complications; at least 40 wives had been infected; and 19 children had contracted the disease at birth. "Many African-Americans are suspicious of the health care system and suspicious of doctors and scientists because there's a legacy of mistreatment," said Phill Wilson, executive director of the Los Angeles-based Black AIDS Institute. "Even though people may or may not know the specifics of the Tuskegee trials, they know that there are health disparities and that blacks often get inferior treatment based on race." VaxGen spokesperson Jim Key said it was difficult for the company to recruit minority participants. "There was still considerable skepticism among people of color regarding medical research and specifically regarding HIV vaccine research. There are so many myths and fears and conspiracy theories regarding HIV," Key said. "My hope is that this will be a catalyst." Balm in Gilead founder Pernessa Seele said that suspicion is so pervasive some blacks believe AIDS was designed to kill them. "It is very important to have black folks in research who understand black culture -- who understand some of the fundamental beliefs we have in our community," Seele said. Back to other CDC news for February 26, 2003 Associated Press 02.26.03; Deborah Kong This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. |
|